| Douglas Trenton Lowery, MD | |
|
1809 Gadsden Hwy, Birmingham, AL 35235-3134 | |
| (205) 838-3755 | |
| (205) 838-3758 |
| Full Name | Douglas Trenton Lowery |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 32 Years |
| Location | 1809 Gadsden Hwy, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609819168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 17441 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Ent And Sinus Center Pc | 8729008388 | 3 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, introduces the Genome Viewer, a new interactive feature on SciVerse ScienceDirect for applicable life sciences journals.
Cerenis Therapeutics, a biopharmaceutical company focused on discovering and developing novel HDL therapies, today announced the completion of a Phase 1 study of the Company's CER-001 investigational product candidate to treat patients with acute coronary syndromes. Results of the completed study provide evidence that the investigational therapy was safe and well-tolerated at all dose levels evaluated, including those intended for future clinical development.
Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.
Patients who had access to GP surgeries with longer opening times in evenings and at weekend visited accident and emergence departments far fewer times than those who did not have similar access to primary care.
March 18-24, 2012 will mark the 50th Anniversary of National Poison Prevention Week (NPPW), first established by Congress in September 1961. As one of the longest continuously running, health and safety campaigns in the United States, the key goal of NPPW is to create national awareness about the risk of injury or death due to poisoning.
› Verified 3 days ago
| Entity Name | Southern Ent & Sinus Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235295973 PECOS PAC ID: 8729008388 Enrollment ID: O20051129000437 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, introduces the Genome Viewer, a new interactive feature on SciVerse ScienceDirect for applicable life sciences journals.
Cerenis Therapeutics, a biopharmaceutical company focused on discovering and developing novel HDL therapies, today announced the completion of a Phase 1 study of the Company's CER-001 investigational product candidate to treat patients with acute coronary syndromes. Results of the completed study provide evidence that the investigational therapy was safe and well-tolerated at all dose levels evaluated, including those intended for future clinical development.
Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.
Patients who had access to GP surgeries with longer opening times in evenings and at weekend visited accident and emergence departments far fewer times than those who did not have similar access to primary care.
March 18-24, 2012 will mark the 50th Anniversary of National Poison Prevention Week (NPPW), first established by Congress in September 1961. As one of the longest continuously running, health and safety campaigns in the United States, the key goal of NPPW is to create national awareness about the risk of injury or death due to poisoning.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Trenton Lowery, MD 1809 Gadsden Hwy, Birmingham, AL 35235-3134 Ph: (205) 838-3755 | Douglas Trenton Lowery, MD 1809 Gadsden Hwy, Birmingham, AL 35235-3134 Ph: (205) 838-3755 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, introduces the Genome Viewer, a new interactive feature on SciVerse ScienceDirect for applicable life sciences journals.
Cerenis Therapeutics, a biopharmaceutical company focused on discovering and developing novel HDL therapies, today announced the completion of a Phase 1 study of the Company's CER-001 investigational product candidate to treat patients with acute coronary syndromes. Results of the completed study provide evidence that the investigational therapy was safe and well-tolerated at all dose levels evaluated, including those intended for future clinical development.
Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.
Patients who had access to GP surgeries with longer opening times in evenings and at weekend visited accident and emergence departments far fewer times than those who did not have similar access to primary care.
March 18-24, 2012 will mark the 50th Anniversary of National Poison Prevention Week (NPPW), first established by Congress in September 1961. As one of the longest continuously running, health and safety campaigns in the United States, the key goal of NPPW is to create national awareness about the risk of injury or death due to poisoning.
› Verified 3 days ago
Dr. Grayson K Rodgers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 502, Birmingham, AL 35205 Phone: 205-933-2951 Fax: 205-933-5893 | |
Dr. Jessica Warren Grayson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Brian Kulbersh, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1940 Elmer J Bissell Rd, Birmingham, AL 35243 Phone: 205-638-4949 Fax: 205-638-4982 | |
Dr. Richard Kailean Mchugh, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, The Kirklin Clinic, Birmingham, AL 35233 Phone: 205-801-8000 | |
Paul F Castellanos, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Dr. David Michael Walters, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1809 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3755 Fax: 205-838-3755 | |
Do Yeon Cho, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |